CURRENT PRACTICE OF PHARMACOVIGILANCE IN TANZANIA. Alex F. Nkayamba, MD. Officer, Clinical Trials and Pharmacovigilance Department

Similar documents
WHO Pharmacovigilance Indicators. Dr. Nitin Gaikwad Co-coordinator, ADR Monitoring Center, PvPI Additional Professor, Pharmacology AIIMS Raipur

Pharmacovigilance in Kenya

Increasing Access to Subsidized Artemisininbased Combination Therapy through Accredited Drug Dispensing Outlets in Tanzania

ADVERSE DRUG REACTION REPORTING KNOWLEDGE, ATTITUDE AND PRACTICES OF COMMUNITY PHARMACY DISPENSERS IN DAR ES SALAAM, TANZANIA

Medicines Safety in WHO: promoting best practices in Pharmacovigilance

REGIONAL REFFERRAL HEALTH MANAGEMENT NEWSLETTER

Creating better cities. together Workshop I.1

Overview of Draft Pharmacovigilance Protocol

Sustainable Drug Seller Initiatives Partners

Tools for Pharmacovigilance and Cohort Event Monitoring

DATA COLLECTION QUESTIONNAIRE

Agenda. Health NKRA Focus Area. HRH Distribution. Health Facilities. Health Commodities RMNCH. Funding Situation. Anticipated Challenges

GUIDELINES ON PROCEDURAL ASPECTS FOR APPLICATIONS FOR MARKETING AUTHORIZATION OF MEDICINAL PRODUCTS

Implementation Status & Results Tanzania Sustainable Management of Mineral Resources (P096302)

Situation Analysis of the. Pharmacovigilance Capacity of. Kenya. Tanzania. Uganda

THE UNITED REPUBLIC OF TANZANIA MINISTRY OF HEALTH AND SOCIAL WELFARE

THE UNITED REPUBLIC OF TANZANIA REPORT OF THE REVIEW OF THE NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME IN TANZANIA JUNE 2000

1. FULL NAME: DR. ALFRED M.E. NABURI 2. SEX MALE 3. ADDRESS

Report of the Tanzania Assessment of Community Services for Childhood Illness. Final December 12, 2012

BUILDING INFRASTRUCTURE FOR ICT DEVELOPMENT IN TANZANIA

PILOT COHORT EVENT MONITORING OF ACTS IN NIGERIA

Engaging the Private Retail Pharmaceutical Sector in TB Case Finding in Tanzania: Pilot Dissemination Meeting Report

Evaluating adverse events from patient support and market research programs: proposed best practices and regulatory changes

LEAD PROJECT INVESTMENT FUND GUIDANCE NOTES

WHO Programme for International Drug Monitoring, Pharmacovigilance Centres & Patient Safety

Accrediting retail drug shops to strengthen Tanzania s public health system: an ADDO case study

Pharmacovigilance & Managed Care Pharmacy. Issues for Medication Safety in Korea

Emergency Plan of Action (EPoA) Tanzania: Floods

MMV Access Symposium Getting Antimalarials to Patients Kampala, Uganda. Accredited Drug Dispensing Outlets: Tanzania Experience

Regulatory Control of Diagnostics in Tanzania. Hiiti Sillo Ag. Director General Tanzania Food and Drugs Authority

TANZANIA: ICT education project amid rural connectivity challenges

Measures of impact of pharmacovigilance processes (3.3)

Corporate Induction: Part 2

Pharmacovigilance improvement and Adverse Drug Reaction Reporting in Iran. By : AMIRMASOUD NIKAHD M.D.

Monitoring and evaluation of Integrated Disease Surveillance and Response in selected districts in Tanzania

Submission to the OIE for official recognition of FMD country status and endorsement of official control programme

Malaria Programme Performance Review Tanzania Mainland

Strategies to Improve Medicine Use Drug and Therapeutics Committees

Tanzania Work Plan FY 2018 Project Year 7

Annual Tanzania Neurosurgery Project Summary: 2013

Mr. Sang-wan, Byun, Vice President of the EXIM Bank of Korea, Members of the Press, Distinguished Guests, Ladies and Gentlemen:

Request for proposals (RFP) For. Operational Research on Tuberculosis. in support of. Challenge TB Project in Tanzania. Issuance Date: 30/1/2018

Introduction to Post-marketing Drug Safety Surveillance: Pharmacovigilance in FDA/CDER

MEDICINES CONTROL COUNCIL

Standard Approaches to Adverse Event Reporting. Jonathan Deutsch, M.D.

The New EU PV Legislation: View from the European Commission

MEDICINES CONTROL COUNCIL

TANZANIA COMMISSION FOR SCIENCE AND TECHNOLOGY (COSTECH) JOB VACANCIES (RE-ADVERTISED)

Direct Patient ADR reporting system in Japan. Kazuhiko Mori, Chief Safety Officer Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Provided below is the background, discussion, and recommendations from the panelists.

MEDICINES CONTROL COUNCIL

Implementing Changes in Pharmacovigilance Regulations. Presented by Dr Ennis H Lee, Senior Partner, TranScrip 14 June 2016

GOOD PRACTICES OF KAIZEN

General Principles of Good Chronic Care

Guideline for Regional Referral Hospital Advisory Board (RRHAB)

Pharmacovigilance in Middle East Conference

Asian Journal of Phytomedicine and Clinical Research Journal home page:

Safeguarding public health. The New PV Legislation its Impact on PV & MI

Good Pharmacovigilance Practice. Overview of GVP Modules on ADR, PSURs, Signal Management and Additional Monitoring Mick Foy - MHRA

Module 2: ICTs for WED

Presentations from the 17 th Joint Annual Health Sector Review Technical Review Meeting

EACCR Reciprocal Monitoring Annet Nanvubya & Elizabeth Ayuo

Guideline on good pharmacovigilance practices (GVP)

Details: Approval: Distribution & Storage: Pharmacovigilance for Researchers for UoL / LTHT Sponsored CTIMPs. Standard Operating Procedure

MONITORING THE SAFETY OF ANTIRETROVIRALS IN SOUTH AFRICA

TANZANIA SECOND SOCIAL ACTION FUND. First Quarter Implementation Progress Report (July - September 2011)

Working Together to Promote Health. Annual Report 2017

Sponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law

Pharmaceutical Sector Country Profile Questionnaire. UNITED REPUBLIC of TANZANIA

New Streams of Risk Management. Tomiko TAWARAGI Chief Safety Officer Pharmaceuticals and Medical Devices Agency (PMDA)

IJBCP International Journal of Basic and Clinical Pharmacology

Gemini Mtei 24 th November

ICT Access and Use in Local Governance in Babati Town Council, Tanzania

Faculties, Universities of Health Sciences (FUCHS) in Tanzania. Prof. John Shao Tuesday, August 04, 2015

REVIEW OF MONITORING OF MALARIA IN PREGNANCY THROUGH NATIONAL HEALTH MANAGEMENT INFORMATION SYSTEMS: TANZANIA

European Patients Academy (EUPATI) Update

3 HEALTH, SAFETY AND ENVIRONMENTAL PROTECTION

O.M.S. Minzi 1 & A.F. Haule 2

Postmarketing Drug Safety and Inspection Readiness

Guideline on good pharmacovigilance practices (GVP)

Targeted technology and data management solutions for observational studies

Helping physicians care for patients Aider les médecins à prendre soin des patients

DR. SUKHPREET SING JUNIOR RESIDENT, DEP'T. OF PHARMACOLOG LUCKNOW, U

May 2017

Safer Obstetrics in Rural Tanzania (SORT) Project Concluded

PRESS RELEASE LAUNCHING OF THE CAPITAL MARKET S UNIVERSITIES AND OTHER HIGHER LEARNING INSITUTIONS CHALLENGE 2018

TANZANIA EMERGENCY PREPAREDNESS AND RESPONSE PLAN (TEPRP)

Tanzania: Joint Social Services Programme Health, Phase II

The Tanzania Quality Improvement Framework in Health Care

Reconfirmation_SOP. - If the letter states that they were. Description/ Scope:

Tanzania Renewable Energy Association (TAREA) Strategy

MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC

THE AFRICAN MEDICINES REGULATORY HARMONIZATION (AMRH) INITIATIVE Accomplishments, Challenges and Path Forward

Draft 2016 Emergency Management Standard Release for Public Comment March 2015

GUIDELINES FOR NATIONAL PHARMACOVIGILANCE SYSTEM MEDICINES CONTROL AGENCY THE GAMBIA

APPLICANT RESOURCE BOOK July 2018

A new pharmaceutical cadre to support supply chain management in rural Primary Health Care facilities [SPEAKERS NAMES]

TERMS OF REFERENCE. Terrorism Prevention Expert (Consultant) Terrorism Prevention Programme. and Kampala, Uganda

Pharmacovigilance Office of Product Review

Habari za Maji prize for outstanding journalism for accountability in water management

Transcription:

CURRENT PRACTICE OF PHARMACOVIGILANCE IN TANZANIA Alex F. Nkayamba, MD Officer, Clinical Trials and Pharmacovigilance Department

PHARMACOVIGILANCE MILESTONES 1989 PV program was first introduced (Tanzania Food and Toxicology information Service) 1993 Tanzania officially implemented spontaneous reporting (Joined WHO International Drug Monitoring program) 1998 PV information incorporated in MoHSW 2003 PV as core function of TFDA with its establishments (TFDA, Act 2003).

METHODS OF PHARMACOVIGILANCE Two methods Passive reporting Yellow forms (ADR forms) English version Swahili version Patient reporting forms ( Swahili) Poor Quality Products Patient alert cards Active surveillance CEM Artemether Lumefantrine (Coartem) & Dihydroartemisin Piperaquine CEM of ARVs (Fund received and sites have been identified)

COHORT EVENT MONITORING OF COARTEM (1) Target 10,000 reports Four (4) regions; Dar es Salaam Mwanza, Arusha and Coast Region ( Kibaha + Bagamoyo) Visits twice, follow up after 7 days Will be closed 2012 6200 (62%) reports have been collected

COHORT EVENT MONITORING OF COARTEM (2) No major events in majority of reports Few events; skin rash, GIT disconforts and no response to treatment Data analysis May 2012 Publication National and scientific news letters

COHORT EVENT MONITORING OF DHA + PPQ Private health facilities in six regions Dar es Salaam, Tanga, Morogoro, Mbeya, Arusha & Mwanza Target 10,000 reports 100 health personnel (doctors, pharmacists and nurses) were trained Visits twice (follow up after 10 days) 2,000 (20%) reports have been collected

CHALLENGES FROM CEM ACTIVITIES Lost to follow up Patient fear of monitored medicines (research?) More labour intensive than SR More costly New to health professionals and PV centers Training required

PASSIVE REPORTING The most common form of ADR reporting. Spontaneous or voluntary reporting. Dependent on the initiative and motivation of the reporters. Cover the whole Tanzanian population Report ADR for all registered medicines Causality assessment is done on receipt of ADR

PV TOOLS Guidelines for Monitoring of Medicines safety Tanzania Pharmacovigilance Training Mannual They are all found on www.tfda.or.tz OTHER TOOLS

REPORTING STRUCTURE.. Eastern Zone Government/Private Health facilities Lake Zone Pharmacovigilance Office, Mtwara TFDA HQ Pharmacovigilance Office, Kigoma Northern Zone Central Zone, Dodoma South highland Zone

WHAT IS DONE ON RECEIPT OF ADR REPORTS Acknowlegement on receipt of ADRs Assessment (Relation btn ADRs vs Susp Medicine) Certain Probably Possibly Not related Entering the data into Vigiflow Done by trained officer Manager review and audit the data before commitment

OUTCOME & CHALLENGES OF ADR REPORTING OUTCOME Additional investigations Recommend restrictions on usage Enhancing educational initiatives on medicine use Regulatory action eg withdraw if situation warrant CHALLENGES Only suspected ADRs are reported Underreporting Reporting bias Lack of denominator Poor at detecting delayed ADRs Deaths poorly reported

WEAK POINTS Information sharing with stakeholders! Publications! Safety bulletins Newsletters (National and International) Capacity of PV Zone officers! Interim data analysis! eg CEM Artemether Lumefantrine

EFFORTS TO IMPROVE PV SYSTM Training of 17 PV officers from PV Zones 10 13 April 12. Procurement of infrastructure for old and new PV Zone offices To conduct regular training and supervision Increase number of PV trained health personnel in private and government facilities Print more IEC materials Increase public awareness by using media (TV, radio, newpaper etc.) National Annual PV meeting (recently resolution)

OBVIOUSLY... If some one want to walk fast... Walk alone! But...

If you want to reach very far Walk with your friends

THANK YOU